Biocon Biologics, Viatris gets European Commission nod for co-developed diabetes drug
Biocon Biologics Ltd, a subsidiary of Biocon Ltd, has got marketing authorisation approval from the European Commission for Kixelle – a biosimilar Ins
12 February 2021, 11:29
